de Visser A - Search Results

1

Frustrated Radical Pairs: From Fleeting Intermediates to Isolable Species.

van der Ze LJC, Hofman J, Mathew S, de Visser A, Brück E, de Bruin B, Chris Slootweg J. van der Ze LJC, et al. Among authors: de visser a. Chemistry. 2024 Nov 8:e202403885. doi: 10.1002/chem.202403885. Online ahead of print. Chemistry. 2024. PMID: 39512211

2

Patterns of corticosterone exposure affect the subcellular localisation of mineralocorticoid and glucocorticoid receptor complexes and gene expression.

Paul SN, De Visser A, Motta F, Rivers CA, Pooley JR, Lightman SL, Meijer OC. Paul SN, et al. Among authors: de visser a. Steroids. 2024 Oct 28;214:109524. doi: 10.1016/j.steroids.2024.109524. Online ahead of print. Steroids. 2024. PMID: 39490722

3

Systemic insecticides for control of stem gall wasp in highbush blueberry.

DeVisser AK, Vandervoort C, Isaacs R, Wise J. DeVisser AK, et al. J Econ Entomol. 2023 Oct 10;116(5):1737-1749. doi: 10.1093/jee/toad162. J Econ Entomol. 2023. PMID: 37598313 Free PMC article.

4

Synergism between the Synthetic Antibacterial and Antibiofilm Peptide (SAAP)-148 and Halicin.

van Gent ME, van der Reijden TJK, Lennard PR, de Visser AW, Schonkeren-Ravensbergen B, Dolezal N, Cordfunke RA, Drijfhout JW, Nibbering PH. van Gent ME, et al. Among authors: de visser aw. Antibiotics (Basel). 2022 May 17;11(5):673. doi: 10.3390/antibiotics11050673. Antibiotics (Basel). 2022. PMID: 35625317 Free PMC article.

5

Long-term immunity after a single yellow fever vaccination in travelers vaccinated at 60 years or older: A 10-year follow-up study.

Rosenstein MD, de Visser AW, Visser LG, Roukens AHE. Rosenstein MD, et al. Among authors: de visser aw. J Travel Med. 2021 Dec 29;28(8):taab126. doi: 10.1093/jtm/taab126. J Travel Med. 2021. PMID: 34401911 Free PMC article.

6

SAAP-148 Eradicates MRSA Persisters Within Mature Biofilm Models Simulating Prosthetic Joint Infection.

Scheper H, Wubbolts JM, Verhagen JAM, de Visser AW, van der Wal RJP, Visser LG, de Boer MGJ, Nibbering PH. Scheper H, et al. Among authors: de visser aw. Front Microbiol. 2021 Jan 29;12:625952. doi: 10.3389/fmicb.2021.625952. eCollection 2021. Front Microbiol. 2021. PMID: 33584628 Free PMC article.

7

Safety and immunogenicity of a primary yellow fever vaccination under low-dose methotrexate therapy-a prospective multi-centre pilot study1.

Bühler S, Jaeger VK, Eperon G, Furrer H, Fux CA, Jansen S, Neumayr A, Rochat L, Schmid S, Schmidt-Chanasit J, Staehelin C, de Visser AW, Visser LG, Niedrig M, Hatz C. Bühler S, et al. Among authors: de visser aw. J Travel Med. 2020 Sep 26;27(6):taaa126. doi: 10.1093/jtm/taaa126. J Travel Med. 2020. PMID: 32729905

8

Response to Dr. Reed.

De Visser A, Hollaar G. De Visser A, et al. Med Teach. 2021 Jan;43(1):113-114. doi: 10.1080/0142159X.2020.1778246. Epub 2020 Jun 24. Med Teach. 2021. PMID: 32579046 No abstract available.

9

Global health electives: Ethical engagement in building global health capacity.

De Visser A, Hatfield J, Ellaway R, Buchner D, Seni J, Arubaku W, Najjuma JN, Hollaar G. De Visser A, et al. Med Teach. 2020 Jun;42(6):628-635. doi: 10.1080/0142159X.2020.1724920. Epub 2020 Feb 21. Med Teach. 2020. PMID: 32083958

10

Long-term immunogenicity after yellow fever vaccination in immunosuppressed and healthy individuals.

Burkhard J, Ciurea A, Gabay C, Hasler P, Müller R, Niedrig M, Fehr J, Villiger P, Visser LG, de Visser AW, Walker UA, Hatz C, Bühler S. Burkhard J, et al. Among authors: de visser aw. Vaccine. 2020 Apr 23;38(19):3610-3617. doi: 10.1016/j.vaccine.2019.12.042. Epub 2020 Jan 5. Vaccine. 2020. PMID: 31911033

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters